Journal rankings · indicator year 2011
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2011
Infectious Diseases journal rankings 2011
131 ranked journals · Subfield in Medicine
Infectious Diseases has 131 ranked journals in 2011. The median journal has an OJR of 1.00, level with the world average of 1.00, down 0.01 on 2010; Q1 starts at OJR 1.64. The top three are New England Journal of Medicine, Clinical Microbiology Reviews, and MMWR Morbidity and Mortality Weekly Report.
Ranks and citation indicators: 2011. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2008–2010, the window the 2011 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery570
- Pulmonary and Respiratory Medicine236
- Cardiology and Cardiovascular Medicine200
- Public Health, Environmental and Occupational Health192
- Oncology150
- Epidemiology139
- Infectious Diseases131
- Endocrinology, Diabetes and Metabolism111
- Neurology109
- Radiology, Nuclear Medicine and Imaging108
- Psychiatry and Mental health107
- Physiology104
Show all 42 subfields
- Orthopedics and Sports Medicine78
- Pediatrics, Perinatology and Child Health68
- Ophthalmology62
- Dermatology60
- Hematology59
- Rheumatology49
- Obstetrics and Gynecology48
- Nephrology41
- Complementary and alternative medicine36
- Pharmacology36
- Reproductive Medicine36
- Emergency Medicine30
- Geriatrics and Gerontology30
- Otorhinolaryngology28
- Pathology and Forensic Medicine21
- Rehabilitation20
- Critical Care and Intensive Care Medicine18
- Immunology and Allergy14
- Genetics12
- Hepatology12
- Urology11
- Anesthesiology and Pain Medicine8
- Gastroenterology6
- Internal Medicine4
- Family Practice2
- Transplantation2
- Biochemistry1
- Anatomy0
- Health Informatics0
- Microbiology0
131 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2010. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2008–2010, the window the 2011 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2008–2010 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2002 to 2011. | Compare |
|---|---|---|---|---|---|---|---|
1New England Journal of MedicineMassachusetts Medical Society · United States | 14.16Q1 | 27.11 0.35 down from 2010 | 2,784 | 35% | — | ||
2Clinical Microbiology ReviewsAmerican Society for Microbiology · United States | 10.83Q1 | 22.14 3.61 up from 2010 | 108 | 97% | — | ||
3MMWR Morbidity and Mortality Weekly ReportOACenters for Disease Control and Prevention · United States | 6.58Q1 | 10.92 2.38 down from 2010 | 38 | 9% | — | ||
4PLoS MedicineOAPublic Library of Science · United States | 5.79Q1 | 12.16 0.64 up from 2010 | 617 | 100% | $6,460 | ||
5PLoS PathogensOAPublic Library of Science · United States | 4.58Q1 | 10.98 0.52 up from 2010 | 1,285 | 100% | $3,043 | ||
6The Lancet Infectious DiseasesElsevier BV · Netherlands | 3.85Q1 | 11.87 2.06 up from 2010 | 383 | 28% | $7,280 | ||
7Annals of Internal MedicineAmerican College of Physicians · United States | 3.52Q1 | 7.87 0.38 down from 2010 | 1,365 | 8% | — | ||
8Clinical Infectious DiseasesOxford University Press · United States | 3.34Q1 | 7.30 0.19 down from 2010 | 2,185 | 48% | $4,763 | ||
9Reviews in Medical VirologyWiley · United Kingdom | 3.03Q1 | 7.44 1.72 up from 2010 | 89 | 29% | $4,880 | ||
10The Journal of Infectious DiseasesOxford University Press · United States | 2.94Q1 | 6.79no change | 1,762 | 62% | $4,763 | ||
11EurosurveillanceOAEuropean Centre for Disease Prevention and Control · Sweden | 2.57Q1 | 6.24 0.97 up from 2010 | 749 | 100% | — | ||
12AIDSLippincott Williams & Wilkins · United Kingdom | 2.51Q1 | 6.63 0.40 up from 2010 | 1,434 | 35% | — | ||
13Emerging infectious diseasesOACenters for Disease Control and Prevention · United States | 2.46Q1 | 4.86 0.50 down from 2010 | 1,782 | 100% | — | ||
14Interdisciplinary Perspectives on Infectious DiseasesOAHindawi Publishing Corporation · United Kingdom | 2.20Q1 | 4.72 0.75 up from 2010 | 61 | 100% | $860 | ||
15Antimicrobial Agents and ChemotherapyOAAmerican Society for Microbiology · United States | 2.16Q1 | 5.47 0.34 up from 2010 | 2,481 | 99% | — | ||
16Journal of Clinical MicrobiologyOAAmerican Society for Microbiology · United States | 2.05Q1 | 4.62 0.16 down from 2010 | 2,476 | 99% | — | ||
17Current HIV/AIDS ReportsSpringer Science+Business Media · United States | 2.03Q1 | 5.29 1.23 up from 2010 | 92 | 50% | $4,190 | ||
18International Journal of Medical MicrobiologyOAElsevier BV · Germany | 1.98Q1 | 5.22 2.46 up from 2010 | 245 | 11% | $3,410 | ||
19Antiviral ResearchElsevier BV · Netherlands | 1.96Q1 | 4.94 0.22 up from 2010 | 479 | 19% | $4,160 | ||
20JAIDS Journal of Acquired Immune Deficiency SyndromesLippincott Williams & Wilkins · United States | 1.96Q1 | 4.96 0.14 up from 2010 | 1,093 | 31% | — | ||
21Journal of Antimicrobial ChemotherapyOxford University Press · United Kingdom | 1.95Q1 | 5.05 0.29 up from 2010 | 1,533 | 40% | $3,784 | ||
22BMC Infectious DiseasesOABioMed Central · United Kingdom | 1.93Q1 | 4.28 0.49 up from 2010 | 753 | 100% | $3,090 | ||
23HIV MedicineWiley · United Kingdom | 1.92Q1 | 3.62 0.53 down from 2010 | 321 | 46% | $4,150 | ||
24AIDS and BehaviorSpringer Science+Business Media · Netherlands | 1.86Q1 | 3.17 0.27 down from 2010 | 515 | 64% | $4,590 | ||
25Clinical Microbiology and InfectionElsevier BV · United Kingdom | 1.84Q1 | 3.94 0.26 up from 2010 | 1,174 | 93% | $3,780 | ||
26AIDS Education and PreventionGuilford Press · United States | 1.75Q1 | 2.89 0.50 up from 2010 | 151 | 44% | — | ||
27American Journal of Infection ControlElsevier BV · United States | 1.71Q1 | 3.25 0.01 up from 2010 | 573 | 13% | $3,360 | ||
28Current Opinion in HIV and AIDSLippincott Williams & Wilkins · United Kingdom | 1.71Q1 | 5.65 1.82 up from 2010 | 269 | 31% | — | ||
29Tropical Medicine & International HealthWiley · United Kingdom | 1.71Q1 | 3.11 0.28 down from 2010 | 688 | 48% | $3,400 | ||
30Future MicrobiologyFuture Medicine · United Kingdom | 1.70Q1 | 3.92 0.78 up from 2010 | 332 | 23% | — | ||
31Infection Control and Hospital EpidemiologyCambridge University Press · United Kingdom | 1.70Q1 | 2.28 0.07 down from 2010 | 1,319 | 26% | $3,550 | ||
32Journal of General VirologyMicrobiology Society · United Kingdom | 1.66Q1 | 3.80 0.14 up from 2010 | 1,123 | 33% | — | ||
33AnaerobeElsevier BV · United Kingdom | 1.64Q1 | 2.92 0.14 up from 2010 | 211 | 10% | $3,350 | ||
34Expert Review of Anti-infective TherapyTaylor & Francis · United Kingdom | 1.64Q2 | 3.51 0.26 up from 2010 | 333 | 27% | — | ||
35Virus ResearchOAElsevier BV · Netherlands | 1.61Q2 | 3.33 0.20 up from 2010 | 746 | 24% | $3,010 | ||
36Infection Genetics and EvolutionOAElsevier BV · Netherlands | 1.59Q2 | 3.40 0.30 down from 2010 | 484 | 27% | $2,730 | ||
37British Journal of Clinical PharmacologyWiley · United Kingdom | 1.57Q2 | 3.08 0.08 up from 2010 | 747 | 91% | $4,780 | ||
38Medical Microbiology and ImmunologySpringer Science+Business Media · Germany | 1.57Q2 | 4.74 1.27 up from 2010 | 105 | 17% | $5,090 | ||
39Microbes and InfectionElsevier BV · France | 1.54Q2 | 3.49 0.04 up from 2010 | 507 | 99% | $3,510 | ||
40Journal of InfectionOAElsevier BV · United Kingdom | 1.52Q2 | 3.68 0.03 up from 2010 | 528 | 7% | $4,030 | ||
41Clinics in Laboratory MedicineElsevier BV · United States | 1.51Q2 | 3.36 0.80 up from 2010 | 151 | 4% | $3,000 | ||
42FEMS Immunology & Medical MicrobiologyOxford University Press · Netherlands | 1.50Q2 | 2.95 0.09 up from 2010 | 423 | 72% | — | ||
43Antiviral TherapyOASAGE Publishing · United Kingdom | 1.50Q2 | 3.06 0.77 down from 2010 | 464 | 49% | $2,800 | ||
44Epidemiology and InfectionOACambridge University Press · United Kingdom | 1.44Q2 | 2.84 0.32 up from 2010 | 718 | 100% | $3,550 | ||
45AIDS CareTaylor & Francis · United Kingdom | 1.41Q2 | 2.56 0.09 up from 2010 | 578 | 42% | — | ||
46InfectionSpringer Science+Business Media · Germany | 1.38Q2 | 3.10 0.26 up from 2010 | 281 | 25% | $4,790 | ||
47AIDS Patient Care and STDsMary Ann Liebert, Inc. · United States | 1.37Q2 | 3.25 0.07 up from 2010 | 329 | 46% | — | ||
48Virology JournalOABioMed Central · United Kingdom | 1.37Q2 | 3.14 0.11 down from 2010 | 770 | 100% | $3,290 | ||
49Diagnostic Microbiology and Infectious DiseaseElsevier BV · United States | 1.35Q2 | 3.17 0.22 up from 2010 | 674 | 17% | $3,290 | ||
50TuberculosisElsevier BV · United Kingdom | 1.35Q2 | 3.76 1.05 up from 2010 | 235 | 35% | $2,690 |
Subfields of Medicine, with Infectious Diseases highlighted.
- Surgery570
- Pulmonary and Respiratory Medicine236
- Cardiology and Cardiovascular Medicine200
- Public Health, Environmental and Occupational Health192
- Oncology150
- Epidemiology139
- Infectious Diseases131
- Endocrinology, Diabetes and Metabolism111
- Neurology109
- Radiology, Nuclear Medicine and Imaging108
- Psychiatry and Mental health107
- Physiology104
- Orthopedics and Sports Medicine78
- Pediatrics, Perinatology and Child Health68
- Ophthalmology62
- Dermatology60
- Hematology59
- Rheumatology49
- Obstetrics and Gynecology48
- Nephrology41
- Complementary and alternative medicine36
- Pharmacology36
- Reproductive Medicine36
- Emergency Medicine30
- Geriatrics and Gerontology30
- Otorhinolaryngology28
- Pathology and Forensic Medicine21
- Rehabilitation20
- Critical Care and Intensive Care Medicine18
- Immunology and Allergy14
- Genetics12
- Hepatology12
- Urology11
- Anesthesiology and Pain Medicine8
- Gastroenterology6
- Internal Medicine4
- Family Practice2
- Transplantation2
- Biochemistry1
- Anatomy0
- Health Informatics0
- Microbiology0
Journals
Citations made in 2011. Corpus-wide, 75.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
55 additional Infectious Diseases journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2008–2010, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2011. Publication window: 2008–2010. How these summaries are calculated
- Ranked journals
- 131
- Window papers (baseline)
- 49,515 +29.7% from indicator year 2008
- Median OJR
- 0.999 -4.1% from indicator year 2008
- Rising journals (2025)
- 48
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2008–2010 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 70 | 73 | 78 | 82 | 86 | 92 | 95 | 101 | 106 | 110 | 118 | 131 | 144 | 162 | 173 | 182 | 189 | 198 | 210 | 217 | 222 | 234 | 243 | 259 | 263 | 258 | |
| Window papers (baseline) | 18,375 | 21,167 | 22,805 | 24,640 | 25,208 | 28,008 | 31,333 | 35,063 | 38,170 | 42,272 | 46,364 | 49,515 | 52,080 | 54,445 | 58,513 | 62,728 | 67,259 | 69,548 | 70,742 | 70,658 | 72,743 | 100,768 | 135,954 | 162,915 | 153,103 | 130,899 | |
| Median OJR | 0.602 | 0.68 | 0.82 | 0.76 | 0.77 | 0.901 | 0.98 | 0.93 | 1.04 | 0.998 | 1.01 | 0.999 | 0.97 | 0.900 | 0.91 | 0.874 | 0.85 | 0.8699 | 0.8696 | 0.83 | 0.80 | 0.597 | 0.61 | 0.64 | 0.70 | 0.75 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.